When was Proof Diagnostics founded?

Proof Diagnostics was founded in 2020.

Where is Proof Diagnostics located?

Proof Diagnostics is headquartered in Cambridge, United States.

How many employees does Proof Diagnostics have?

As of Jun 30, 2026, the latest employee count at Proof Diagnostics is 1.

Is Proof Diagnostics a funded company?

Proof Diagnostics is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Proof Diagnostics rank among its competitors?

Proof Diagnostics ranks 13th amongst 59 active competitors, of which 3 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Curative, which secured $153M in Oct, 2025.

Who are the top competitors of Proof Diagnostics?

Proof Diagnostics' top competitors include Pictor, Curative and Aptitude Medical. Among them, Curative secured the most recent funding round in October, 2025.

Proof Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Proof Diagnostics is an acquired company based in Cambridge (United States), founded in 2020 by Feng Zhang, Jonathan Gootenberg and Omar Abudayyeh. It operates as a Manufacturer of CRISPR based Covid-19 molecular testing device. The company has 59 active competitors, including 3 funded and 5 that have exited. Its top competitors include companies like Pictor, Curative and Aptitude Medical.

Company Details

Website: proofdx.com
Social
Email ID: *****@proofdx.com
Part Of

Key Metrics

Founded Year

2020

Location

Cambridge, United States

Stage

Acquired

Investors

F-Prime Capital & 1 more

Ranked

13^th among 59 active competitors

Employee Count

1 as on Jun 30, 2026

Similar Companies

Pictor & 81 more

Exit Details

Acquired by Ginkgo Bioworks (Feb 28, 2024)

View Proof Diagnostics' full profile

Proof Diagnostics got acquired by Ginkgo Bioworks on Feb 28, 2024.

Click here to take a look at Proof Diagnostics's acquisition in detail

Proof Diagnostics is a funded company. Proof Diagnostics has 2 institutional investors.

View details of Proof Diagnostics's funding rounds and investors

The founders of Proof Diagnostics are Feng Zhang, Jonathan Gootenberg and Omar Abudayyeh.

Here are the details of Proof Diagnostics' key team members:

Feng Zhang: Co-Founder of Proof Diagnostics and founder of 1 other company. They serve on the board of 1 company.
Jonathan Gootenberg: Co-Founder of Proof Diagnostics.
Omar Abudayyeh: Co-Founder of Proof Diagnostics.

View details of Proof Diagnostics's Founder profiles and Board Members

Proof Diagnostics' employee count trend

Proof Diagnostics has 1 employees as of Jun 26. Here is Proof Diagnostics's employee count trend over the years:

Employee count trend for Proof Diagnostics

Uncover Proof Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Proof Diagnostics include Pictor, Curative and Aptitude Medical. Here is the list of Top 10 competitors of Proof Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Pictor 2005, Auckland (New Zealand), Series A	Developer of immunodiagnostic products based on multiplexed assays	$11.1M	K1W1, Cure Kids Ventures & 41 others	60/100
2nd	Curative 2020, Austin (United States), Series B	Provider of self collecting COVID-19 testing centers listing platform	$162M	Upside Vision Fund, DCVC & 12 others	57/100
3rd	Aptitude Medical 2011, Goleta (United States), Funding Raised	Democratizing diagnostics with accessible, lab-quality molecular testing solutions	-	Gates, TSVC & 2 others	50/100
4th	Kriya 2006, Chennai (India), Series A	Developer of health care products for diagnosis and treatment	$4.5M	S A S Fininvest, MG INDUSTRIAL HOLDINGS & 5 others	45/100
5th	Sense Biodetection 2014, Abingdon (United Kingdom), Acquired	Provider of point of care molecular diagnostics solutions	$79.2M	Earlybird, Koch Disruptive Technologies & 27 others	43/100
6th	Biolidics 2009, Singapore (Singapore), Public	Provider of cell enrichment systems for cancer diagnosis and treatment	-	SEEDS Capital, NUS Enterprise & 1 others	41/100
7th	Digital Diagnostics 2019, Mainz (Germany), Unfunded	Provider of AI-based real-time diagnostics devices for SARS-CoV-2 testing	-	-	41/100
8th	Pearsanta 2023, Richmond (United States), Unfunded	Medical diagnostic and innovation company delivering personalized healthcare solutions	-	-	40/100
9th	Rover Diagnostics 2018, New York City (United States), Funding Raised	Developer of portable PCR diagnostic devices for the diagnosis of infectious diseases	-	Harlem Biospace	39/100
10th	SQI Diagnostics 1999, Toronto (Canada), Public	Developer of multiplexed tests and automated systems for biological testing.	-	Wallmine	35/100
13th	Proof Diagnostics 2020, Cambridge (United States), Acquired	Manufacturer of CRISPR based Covid-19 molecular testing device	-	F-Prime Capital, Madrona	31/100